188404-10-6
188404-10-6 結(jié)構(gòu)式
基本信息
中文別名
化合物 T15948甲基花生四烯酸氟磷酸酯
((5Z,8Z,11Z,14Z)-二十碳-5,8,11,14-四烯-1-基)氟磷酸甲酯
英文別名
MAPFMAFP
Phosphonofluoridicacid
METHYL ARACHIDONYL FLUOROPHOSPHONATE
(5Z,8Z,11Z,14Z)-5,8,11,14-Eicosatetraenylmethylester
METHYLPHOSPHONOFLUORIDIC ACID 5,8,11,14-EICOSATETRAENYL ESTER
5Z,8Z,11Z,14Z-EICOSATETRAENYL-PHOSPHONOFLUORIDIC ACID, METHYL ESTER
Phosphonofluoridic acid, methyl-5Z,8Z,11Z,14Z-eicosatetraenyl ester
(all-Z)-5,8,11,14-Eicosatetraenylphosphonofluoridic Acid Methyl Ester
(5Z,8Z,11Z,14Z)-1-[fluoro(methoxy)phosphoryl]icosa-5,8,11,14-tetraene
物理化學(xué)性質(zhì)
沸點455.3±34.0 °C(Predicted)
密度0.960±0.06 g/cm3(Predicted)
RTECS號TA8108000
閃點-16 °C
儲存條件-70°C
溶解度DMF: 3 mg/ml; DMSO: 3 mg/ml; Ethanol: 3.5 mg/ml; Ethanol:PBS (pH 7.2) 1:1: .5 mg/ml; PBS (7.2): <1 mg/ml (colloidal suspension
形態(tài)methyl acetate solution
顏色Light yellow to yellow
敏感性空氣敏感
InChI1S/C21H36FO2P/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-25(22,23)24-2/h7-8,10-11,13-14,16-17H,3-6,9,12,15,18-21H2,1-2H3/b8-7-,11-10-,14-13-,17-16-
InChIKeyKWKZCGMJGHHOKJ-ZKWNWVNESA-N
SMILESCCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCCP(F)(=O)OC
安全數(shù)據(jù)
警示詞危險
危險性描述H225-H319-H336
危險品標志F,Xi
危險類別碼11-36-66-67
安全說明16-26-29-33
危險品運輸編號UN 1231 3/PG 2
WGK Germany1
存儲類別3 - Flammable liquids
危險性類別Eye Irrit. 2
Flam. Liq. 2
STOT SE 3
Flam. Liq. 2
STOT SE 3
188404-10-6價格(試劑級)
| 報價日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
| 2025/12/22 | HY-103334 | 188404-10-6 MAFP | 188404-10-6 | 1mg (26.99 mM * 100 μL in Methyl acetate) | 600元 |
| 2025/12/22 | HY-103334 | 188404-10-6 MAFP | 188404-10-6 | 5mg (26.99 mM * 500 μL in Methyl acetate) | 1280元 |
| 2025/12/22 | HY-103334 | 188404-10-6 MAFP | 188404-10-6 | 10 mg (26.99 mM * 1 mL in Methyl acetate) | 2180元 |
常見問題列表
生物活性
MAFP (Methyl Arachidonyl Fluorophosphonate) 是選擇性，針對活性位點，不可逆的 cPLA2 和 iPLA2 抑制劑。 MAFP也是一種有效的不可逆的 anandamide amidase 抑制劑。靶點
cPLA2, iPLA2, Anandamide amidase
體外研究
MAFP inhibits iPLA2, in a concentration-dependent manner with an IC 50 of 5 μM after a 5 min preincubation at 40°C in P388D1 cells. cPLA, is a phospholipid hydrolase using the hydroxyl of serine-228 residue as its catalytic nucleophile. MAFP is also an inhibitor of anandamide amidase and as a ligand for the CB1 cannabinoid receptor. MAFP demonstrates selectivity towards anandamide amidase for which it is approximately 3000 and 30000-fold more potent than it is towards chymotrypsin and trypsin, respectively. MAFP displaces [ 3 H]CP-55940 binding to the CB1 cannabinoid receptor with an IC 50 of 20 nM vs 40 nM for anandamide.